BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7801988)

  • 1. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    Am J Hosp Pharm; 1992 Nov; 49(11):2769-72. PubMed ID: 1471644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
    Burm JP; Jhee SS; Chin A; Moon YS; Jeong E; Nii L; Fox JL; Gill MA
    Am J Hosp Pharm; 1994 May; 51(9):1201-4. PubMed ID: 7913797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shelf lives of aseptically prepared medicines--stability of piperacillin/tazobactam in PVC and non-PVC bags.
    Rigge DC; Jones MF
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):339-43. PubMed ID: 16085149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
    Hassan E; Leslie J; Martir-Herrero ML
    Am J Hosp Pharm; 1994 Sep; 51(17):2143-5. PubMed ID: 7985689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Mar; 51(5):672-8. PubMed ID: 8203388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of ranitidine admixtures frozen and refrigerated in minibags.
    Lampasona V; Mullins RE; Parks RB
    Am J Hosp Pharm; 1986 Apr; 43(4):921-5. PubMed ID: 3706338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature.
    Galante LJ; Stewart JT; Warren FW; Johnson SM; Duncan R
    Am J Hosp Pharm; 1990 Jul; 47(7):1580-4. PubMed ID: 2368751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of piperacillin sodium in the presence of tazobactam sodium in 5% dextrose and normal saline injections.
    Mathew M; Das Gupta V; Bethea C
    J Clin Pharm Ther; 1994 Dec; 19(6):397-9. PubMed ID: 7876373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
    Leung E; Venkatesan N; Ly SC; Scheetz MH
    Am J Health Syst Pharm; 2013 Jul; 70(13):1163-6. PubMed ID: 23784164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
    Bullock L; Parks RB; Lampasona V; Mullins RE
    Am J Hosp Pharm; 1985 Dec; 42(12):2683-7. PubMed ID: 3936354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of esmolol hydrochloride in intravenous solutions.
    Baaske DM; Dykstra SD; Wagenknecht DM; Karnatz NN
    Am J Hosp Pharm; 1994 Nov; 51(21):2693-6. PubMed ID: 7856582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
    Chung KC; Moon YS; Chin A; Ulrich RW; Gill MA
    Am J Health Syst Pharm; 1995 Jul; 52(14):1554-6. PubMed ID: 7552901
    [No Abstract]   [Full Text] [Related]  

  • 16. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25 degrees C.
    Bosso JA; Prince RA; Fox JL
    Am J Hosp Pharm; 1992 Sep; 49(9):2223-5. PubMed ID: 1388000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
    Belliveau PP; Nightingale CH; Quintiliani R
    Am J Hosp Pharm; 1994 Apr; 51(7):901-4. PubMed ID: 8017440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1984 Apr; 41(4):686-9. PubMed ID: 6720710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the stability of ranitidine hydrochloride in total parenteral nutrient mixtures.
    Williams MF; Hak LJ; Dukes G
    Am J Hosp Pharm; 1990 Jul; 47(7):1574-9. PubMed ID: 2114791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.